This study investigated the immunophenotyping data of patients with mature B‐cell malignancies, and developed a new combined score including CD43 and CD180 which could improve the diagnostic value of CLL versus non‐CLL, particularly in atypical CLL. Here, CD180 is linked to B-cell chronic lymphocytic leukemia.